Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Lung cancer screening program navigators improve adherence and patient experience. However, little is known about how navigators improve program outcomes.

Objective: The aim of this qualitative study was to explore factors influencing the lung cancer screening program navigator role.

Design: From December 2020 to September 2021, we conducted a cross-sectional qualitative study of in-depth interviews in the Veterans Health Administration.

Participants: We interviewed a national sample of healthcare team members involved in lung cancer screening at 10 Veterans Affairs Medical Centers.

Approach: We performed interviews to elicit data on lung cancer screening team and organizational characteristics, barriers to and facilitators of lung cancer screening, and factors influencing the navigator role. We utilized an iterative inductive-deductive approach for qualitative analysis based on the health systems science framework and relational coordination theory.

Participants: We conducted 30 interviews (participation rate = 56%). The 30 participants were predominantly physicians (47%), in primary care (33%), and with 1-10 years of experience in current role (37%).

Key Results: Participants indicated that both structural and relational factors influence the lung cancer screening program navigator role. Specifically, organizational support to strengthen the navigator's ability to function as a boundary spanner emerged as a key factor that can influence program outcomes such as efficient enrollment practices and program growth.

Conclusions: Healthcare team members involved in lung cancer screening indicated that navigators play an important role in impacting lung cancer screening programs. As lung cancer screening programs continue to evolve and expand, developing organizational structure and relational coordination to support navigators can positively impact program outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11606-025-09714-0DOI Listing

Publication Analysis

Top Keywords

lung cancer
40
cancer screening
40
screening program
16
factors influencing
12
program navigator
12
navigator role
12
lung
10
cancer
10
screening
10
influencing lung
8

Similar Publications

Purpose: mutations are classically seen in non-small cell lung cancers (NSCLCs), and EGFR-directed inhibitors have changed the therapeutic landscape in patients with -mutated NSCLC. The real-world prevalence of -mutated ovarian cancers has not been previously described. We aim to determine the prevalence of pathogenic or likely pathogenic mutations in ovarian cancer and describe a case of -mutated metastatic ovarian cancer with a durable response to osimertinib, an EGFR-directed targeted therapy.

View Article and Find Full Text PDF

Reply to: Comments on the Study of Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With -Mutant Lung Cancer.

JCO Precis Oncol

September 2025

Monica F. Chen, MD, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, Daniel Gomez, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, and Helena A. Yu, MD, Division of Solid Tumor Oncology, Depart

View Article and Find Full Text PDF

Objectives: The 9th edition of the Tumor, Node, Metastasis (TNM-9) lung cancer classification is set to replace the 8th edition (TNM-8) starting in 2025. Key updates include the splitting of the mediastinal nodal category N2 into single- and multiple-station involvement, as well as the classification of multiple extrathoracic metastatic lesions as involving a single organ system (M1c1) or multiple organ systems (M1c2). This study aimed to assess how the TNM-9 revisions affect the final staging of lung cancer patients and how these changes correlate with overall survival (OS).

View Article and Find Full Text PDF